Akaal Pharma

Akaal Pharma is a clinical-stage drug discovery and development biopharmaceutical company focused on developing novel drugs for the treatment of autoimmune, inflammatory and immune diseases. Akaal Pharma has created a pipeline of new small molecule drugs for the treatment of atopic dermatitis, psoriasis, arthritis pain, multiple sclerosis (MS) and ulcerative colitis (UC). 
Akaal Pharma applies its proprietary medicinal chemistry and drug discovery platform coupled with broad and in-depth drug discovery and development expertise of our leadership team. 
Akaal Pharma has strong portfolio of intellectual property/patents on its internally discovered drug candidates. Several patents have been issued including in the US, Europe, Japan, China, Australia and New Zealand. The remaining patents to be issued in Canada, India and other countries are in the process. Akaal Pharma has successfully completed multiple Phase-1 (proof of concept)clinical trials of its First-in-Class Topical treatment for atopic dermatitis, psoriasis and arthritis. Akaal Pharma's is also developing novel, safer and effective small molecule oral drugs for the treatment of MS, UC and other autoimmune diseases.

Co-Founder & Vice President

Kilostate 

Kilostate is an independent letting agent offering specialist advice on residential properties in South London & Surrey. With three decades of experience in the property industry coupled with the largest property portfolio in South London, our reputation and experience is unrivaled.

Managing Director

Akaal Property

Akaal Property is a leading property company based in London. Whether you are a developer, investor or landlord; return on investment and performance based asset management remain your constant objectives. We have all the in-house strategic property management and asset management skills required to achieve this.

Founder & Director

Bobby Sandhu founder & director of Akaal Capital the holding company for: 

Akaal Property a privately owned property investmemt company alongside its property management company Kilostate. Combined they containing a private investment portfolio worth upward of £250M with over 500 properties currently under management in London. 

Akaal Pharma a privately owned clinical-stage biotech company focused on advancing the clinical development of its internally discovered topical and oral small molecule drug candidates for treating inflammatory, immune and vascular diseases. Our drug pipine has already secured deals for potential milestone revenues of up to $800M.

Bobby is involved in the day-to-day operations of the business including finance, future growth opportunities and business development of the above mentioned companies as well as consulting on various joint ventures and startups.

Taplio

Bobby Sandhu's Linkedin Analytics

Want to drive more opportunities from LinkedIn?

Taplio

.css-1jgreyo{background-image:linear-gradient(284deg, rgba(39,43,72,1) 0%, rgba(33,47,183,1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}Bobby Sandhu's Linkedin Analytics

Want to drive more opportunities from LinkedIn?

Bobby Sandhu's Linkedin Analytics